2021•Unpublished venueOpen access

Novel Neurological and Anti-epileptic Drug of Combined Valproic acid and Topiramate (TopVal).

Mina Kelleni

Abstract

In this communication we demonstrate the development of a novel neurological compound of combined valproic acid and topiramate (TopVal) which might offer a potential therapeutic option for epilepsy, refractory epilepsy as well as other neurological diseases currently managed by either drug. A lower administered dose might help to achieve a higher safety profile when enrolled for randomized clinical trials against either drug.

Open-access reader

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Topiramate, Valproic Acid, Epilepsy, Medicine, Drug, Refractory (planetary science), Antiepileptic drug, Clinical trial